vs

Side-by-side financial comparison of PACS Group, Inc. (PACS) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.

PACS Group, Inc. is the larger business by last-quarter revenue ($1.4B vs $766.5M, roughly 1.8× SCANSOURCE, INC.). PACS Group, Inc. runs the higher net margin — 4.4% vs 2.2%, a 2.2% gap on every dollar of revenue. On growth, PACS Group, Inc. posted the faster year-over-year revenue change (18.4% vs 2.5%). Over the past eight quarters, PACS Group, Inc.'s revenue compounded faster (20.5% CAGR vs 0.9%).

ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.

PACS vs SCSC — Head-to-Head

Bigger by revenue
PACS
PACS
1.8× larger
PACS
$1.4B
$766.5M
SCSC
Growing faster (revenue YoY)
PACS
PACS
+15.9% gap
PACS
18.4%
2.5%
SCSC
Higher net margin
PACS
PACS
2.2% more per $
PACS
4.4%
2.2%
SCSC
Faster 2-yr revenue CAGR
PACS
PACS
Annualised
PACS
20.5%
0.9%
SCSC

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
PACS
PACS
SCSC
SCSC
Revenue
$1.4B
$766.5M
Net Profit
$59.7M
$16.5M
Gross Margin
13.4%
Operating Margin
7.0%
2.3%
Net Margin
4.4%
2.2%
Revenue YoY
18.4%
2.5%
Net Profit YoY
3022.5%
-3.3%
EPS (diluted)
$0.42
$0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PACS
PACS
SCSC
SCSC
Q4 25
$1.4B
$766.5M
Q3 25
$1.3B
$739.6M
Q2 25
$1.3B
$812.9M
Q1 25
$1.3B
$704.8M
Q4 24
$1.1B
$747.5M
Q3 24
$1.0B
$775.6M
Q2 24
$981.4M
$746.1M
Q1 24
$934.3M
$752.6M
Net Profit
PACS
PACS
SCSC
SCSC
Q4 25
$59.7M
$16.5M
Q3 25
$52.4M
$19.9M
Q2 25
$51.0M
$20.1M
Q1 25
$28.5M
$17.4M
Q4 24
$1.9M
$17.1M
Q3 24
$15.6M
$17.0M
Q2 24
$-10.9M
$16.1M
Q1 24
$49.1M
$12.8M
Gross Margin
PACS
PACS
SCSC
SCSC
Q4 25
13.4%
Q3 25
14.5%
Q2 25
12.9%
Q1 25
14.2%
Q4 24
13.6%
Q3 24
17.1%
13.1%
Q2 24
22.3%
13.0%
Q1 24
21.2%
12.6%
Operating Margin
PACS
PACS
SCSC
SCSC
Q4 25
7.0%
2.3%
Q3 25
6.4%
3.5%
Q2 25
6.2%
3.3%
Q1 25
3.8%
3.2%
Q4 24
1.7%
2.5%
Q3 24
2.2%
2.3%
Q2 24
0.1%
2.9%
Q1 24
8.6%
2.3%
Net Margin
PACS
PACS
SCSC
SCSC
Q4 25
4.4%
2.2%
Q3 25
3.9%
2.7%
Q2 25
3.9%
2.5%
Q1 25
2.2%
2.5%
Q4 24
0.2%
2.3%
Q3 24
1.5%
2.2%
Q2 24
-1.1%
2.2%
Q1 24
5.3%
1.7%
EPS (diluted)
PACS
PACS
SCSC
SCSC
Q4 25
$0.42
$0.75
Q3 25
$0.32
$0.89
Q2 25
$0.31
$0.87
Q1 25
$0.17
$0.74
Q4 24
$-0.03
$0.70
Q3 24
$0.10
$0.69
Q2 24
$-0.07
$0.66
Q1 24
$0.38
$0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PACS
PACS
SCSC
SCSC
Cash + ST InvestmentsLiquidity on hand
$197.0M
$83.5M
Total DebtLower is stronger
$353.2M
Stockholders' EquityBook value
$946.8M
$910.9M
Total Assets
$5.6B
$1.7B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PACS
PACS
SCSC
SCSC
Q4 25
$197.0M
$83.5M
Q3 25
$355.7M
$124.9M
Q2 25
$294.2M
$126.2M
Q1 25
$287.5M
$146.3M
Q4 24
$157.7M
$110.5M
Q3 24
$49.5M
$145.0M
Q2 24
$73.4M
$185.5M
Q1 24
$81.2M
$159.1M
Total Debt
PACS
PACS
SCSC
SCSC
Q4 25
$353.2M
Q3 25
Q2 25
Q1 25
Q4 24
$411.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PACS
PACS
SCSC
SCSC
Q4 25
$946.8M
$910.9M
Q3 25
$871.3M
$914.0M
Q2 25
$806.8M
$906.4M
Q1 25
$750.2M
$901.7M
Q4 24
$709.6M
$900.7M
Q3 24
$660.0M
$920.9M
Q2 24
$572.1M
$924.3M
Q1 24
$128.0M
$944.1M
Total Assets
PACS
PACS
SCSC
SCSC
Q4 25
$5.6B
$1.7B
Q3 25
$5.6B
$1.7B
Q2 25
$5.5B
$1.8B
Q1 25
$5.5B
$1.7B
Q4 24
$5.2B
$1.7B
Q3 24
$4.5B
$1.8B
Q2 24
$3.9B
$1.8B
Q1 24
$3.9B
$1.8B
Debt / Equity
PACS
PACS
SCSC
SCSC
Q4 25
0.37×
Q3 25
Q2 25
Q1 25
Q4 24
0.58×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PACS
PACS
SCSC
SCSC
Operating Cash FlowLast quarter
$-3.4M
$30.8M
Free Cash FlowOCF − Capex
$28.9M
FCF MarginFCF / Revenue
3.8%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
-0.06×
1.87×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PACS
PACS
SCSC
SCSC
Q4 25
$-3.4M
$30.8M
Q3 25
$204.8M
$23.2M
Q2 25
$52.6M
Q1 25
$150.2M
$66.1M
Q4 24
$64.6M
$-6.2M
Q3 24
$209.2M
$44.8M
Q2 24
$34.8M
Q1 24
$58.8M
$160.2M
Free Cash Flow
PACS
PACS
SCSC
SCSC
Q4 25
$28.9M
Q3 25
$20.8M
Q2 25
Q1 25
$64.6M
Q4 24
$-8.2M
Q3 24
$42.5M
Q2 24
Q1 24
$157.7M
FCF Margin
PACS
PACS
SCSC
SCSC
Q4 25
3.8%
Q3 25
2.8%
Q2 25
Q1 25
9.2%
Q4 24
-1.1%
Q3 24
5.5%
Q2 24
Q1 24
21.0%
Capex Intensity
PACS
PACS
SCSC
SCSC
Q4 25
0.3%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.2%
Q4 24
0.3%
Q3 24
0.3%
Q2 24
0.2%
Q1 24
0.3%
Cash Conversion
PACS
PACS
SCSC
SCSC
Q4 25
-0.06×
1.87×
Q3 25
3.91×
1.17×
Q2 25
1.03×
Q1 25
5.28×
3.79×
Q4 24
33.78×
-0.36×
Q3 24
13.39×
2.64×
Q2 24
Q1 24
1.20×
12.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PACS
PACS

Segment breakdown not available.

SCSC
SCSC

Products And Services$723.4M94%
Intelisys Advisory$25.0M3%
Recurring Revenue$18.2M2%

Related Comparisons